CN Stock MarketDetailed Quotes

301277 Newland Pharmaceutical

Watchlist
  • 14.43
  • +0.15+1.05%
Noon Break Dec 27 11:30 CST
4.04BMarket Cap24.62P/E (TTM)

About Newland Pharmaceutical Company

The company was founded in 2005 with a registered capital of 99 million yuan and current assets of 0.57 billion yuan. Mainly engaged in R&D, production and sales of pharmaceutical intermediates and fine chemicals. The company is mainly engaged in the production, development and sale of pharmaceutical intermediates, APIs and chemical preparations. The company's main products are L-p-hydroxyphenylglycine series products and p-toluene sulfonate products. The company received the honor of “Waste-free Factory” in Xuchang City.

Company Profile

Short Name-A新天地
Symbol-A301277
Company NameNewland Pharmaceutical Co., Ltd.
Listing DateNov 16, 2022
Issue Price27.00
Shares Offered33.36M share(s)
FoundedSep 15, 2005
Legal Representativejianzhong xie
General Managerluwei zhang
Secretaryyanzi wu
Accounting FirmGrant Thornton Certified Public Accountants (Special General Partnership)
Securities Representativeyanzi wu
Legal CounselBeijing Tianyuan Law Firm
Employees937
Phone0374-6103777
Office AddressEast side of the southern section of Weiwu Road, Changge City
Zip Code461500
Registered AddressEast side of the southern section of Weiwu Road, Changge City, Xuchang City, Henan Province
Fax0374-6105968
Emailboard@hnnewland.com
Business License411082100006960
BusinessProduction, development, and sale of pharmaceutical intermediates, APIs, and chemical preparations (excluding hazardous chemicals, with the exception of products prohibited by the country); import and export of goods or technology (excluding imports and exports of goods and technology prohibited by the country or involving administrative examination and approval).

Company Executives

  • Name
  • Position
  • Salary
  • jianzhong xie
  • Chairman, Directors, Nomination Committee Members, Chairman of the Strategy Committee, Member of the Remuneration and Assessment Committee, Audit Committee Member
  • 567.30K
  • wanmin liu
  • Vice Chairman, Directors
  • 438.90K
  • hongmin liu
  • Directors
  • 600.00K
  • chao liu
  • Directors, Deputy General Manager, Chief Engineer
  • 401.80K
  • binggang zhang
  • Directors
  • --
  • luwei zhang
  • Directors, General Manager, Strategy Committee Member
  • 482.40K
  • yu ke
  • Independent Directors, Chairman of the Nomination Committee, Strategy Committee Member, Member of the Remuneration and Assessment Committee
  • 60.00K
  • jingbao wang
  • Independent Directors, Audit Committee Member, Nomination Committee Members
  • 60.00K
  • faliang jia
  • Independent Directors, Chairman of the Audit Committee, Chairman of the Remuneration and Assessment Committee
  • 60.00K
  • yanzi wu
  • Board Secretary, Securities Affairs Representative
  • 156.20K
  • heping xu
  • Chairman of the Supervisory Board, Auditors
  • --
  • zhangchun liu
  • Auditors
  • --
  • liying wang
  • Deputy General Manager
  • 303.90K
  • qingkui wang
  • Chief Financial Officer
  • 379.70K
  • weidong wu
  • Employee Supervisors
  • 122.80K